FDA Ephedrine Adverse Event Data Questioned By GAO
This article was originally published in The Tan Sheet
Executive Summary
FDA's scientific justification for its proposed rule restricting the use of ephedrine alkaloids in dietary supplements is "open to question," GAO says in a report on the ephedrine proposed rule issued Aug. 4.